Dr James Thomas Barber Jr, DO - Medicare Obstetrics/gynecology in Anchorage, AK

Dr James Thomas Barber Jr, DO is a medicare enrolled "Obstetrics & Gynecology - Maternal & Fetal Medicine" physician in Anchorage, Alaska. He went to Philadelphia College Of Osteopathic Medicine and graduated in 1996 and has 28 years of diverse experience with area of expertise as Obstetrics/gynecology. He is a member of the group practice Providence Health And Services- Washington and his current practice location is 3831 Piper St Ste Sll020, Anchorage, Alaska. You can reach out to his office (for appointments etc.) via phone at (907) 212-3470.

Dr James Thomas Barber Jr is licensed to practice in Alaska (license number 130691) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1013903665.

Contact Information

Dr James Thomas Barber Jr, DO
3831 Piper St Ste Sll020,
Anchorage, AK 99508-4699
(907) 212-3470
(907) 212-3474



Physician's Profile

Full NameDr James Thomas Barber Jr
GenderMale
SpecialityObstetrics/gynecology
Experience28 Years
Location3831 Piper St Ste Sll020, Anchorage, Alaska
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr James Thomas Barber Jr attended and graduated from Philadelphia College Of Osteopathic Medicine in 1996
  NPI Data:
  • NPI Number: 1013903665
  • Provider Enumeration Date: 09/20/2005
  • Last Update Date: 04/27/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 8527132778
  • Enrollment ID: I20180420001430

Medical Identifiers

Medical identifiers for Dr James Thomas Barber Jr such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1013903665NPI-NPPES
30121215OtherPAAMERIHEALTH MERCY
415529OtherPAUPMC
551160700MedicaidMD
1616712OtherPAHIGHMARK BLUE SHIELD
30132080OtherPAAMERIHEALTH MERCY - WMG
30139630OtherPAAMERIHEALTH MERCY - YHOBGYN
1526925OtherPAGATEWAY
2284693MedicaidOH
30122964OtherPAAMERIHEALTH MERCY - YH
34-00-7597OtherOHOHIO LICENSE NUMBER

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207V00000XObstetrics & Gynecology 34-00-7597 (Ohio)Secondary
207VM0101XObstetrics & Gynecology - Maternal & Fetal Medicine 02004386A (Indiana)Secondary
207VM0101XObstetrics & Gynecology - Maternal & Fetal Medicine OS009700L (Pennsylvania)Secondary
207VM0101XObstetrics & Gynecology - Maternal & Fetal Medicine 130691 (Alaska)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Providence Health And Services- Washington1557408176145

News Archive

Americans sicker but live longer than the English: Study

According to a new study in the journal Demographics, and elderly American is not quite as healthy as his English counterpart, but does live just as long, if not longer. The study found that Americans aged 55 to 64 and 70 to 80 had higher rates of chronic diseases than same-aged English people, but they died at about the same rate. Americans aged 65 and older could be sicker than their English peers but lived longer.

Champions Biotechnology signs agreement to test Cephalon's CEP-32496 in Biomerk Tumorgraft platform

Champions Biotechnology, Inc., an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, announced the establishment of an agreement with Cephalon, Inc., a global biopharmaceutical company, for the testing of the Cephalon novel B-Raf inhibitor CEP-32496 in Champions' Biomerk Tumorgraft™ platform.

ADAGIO clinical trial results demonstrating AZILECT's efficacy published

Results from the ADAGIO trial, published online today in The New England Journal of Medicine, demonstrated that Parkinson's disease patients receiving AZILECT (rasagiline) 1mg/day at the start of the study (early-start group) experienced superior benefit over 18 months compared with those who started the exact same treatment nine months later (delayed-start group).

Thiazolidinedione (TZD) class of anti-diabetic drugs may be a potential targeted therapy for myeloma patients

In laboratory tests on multiple myeloma cells, University of Rochester researchers found that this type of cancer expresses a protein that makes it an easy target for an existing class of diabetes drugs. After more investigation, they hope the discovery will lead to a new, targeted therapy for myeloma patients.

SonoSite to showcase the NanoMaxx ultrasound tool for vascular access applications at AVA

SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried and point-of-care ultrasound, announced today new patient safety technology, mobile power solutions and image quality advances for vascular access applications. The company will be showcasing the new products and capabilities at the annual scientific meeting of the Association for Vascular Access (AVA) being held in Las Vegas September 14th - 18th, 2009.

Read more Medical News

› Verified 2 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr James Thomas Barber Jr allows following entities to bill medicare on his behalf.
Entity NameProvidence Health & Services- Washington
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1093956278
PECOS PAC ID: 1557408176
Enrollment ID: O20091029000679

News Archive

Americans sicker but live longer than the English: Study

According to a new study in the journal Demographics, and elderly American is not quite as healthy as his English counterpart, but does live just as long, if not longer. The study found that Americans aged 55 to 64 and 70 to 80 had higher rates of chronic diseases than same-aged English people, but they died at about the same rate. Americans aged 65 and older could be sicker than their English peers but lived longer.

Champions Biotechnology signs agreement to test Cephalon's CEP-32496 in Biomerk Tumorgraft platform

Champions Biotechnology, Inc., an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, announced the establishment of an agreement with Cephalon, Inc., a global biopharmaceutical company, for the testing of the Cephalon novel B-Raf inhibitor CEP-32496 in Champions' Biomerk Tumorgraft™ platform.

ADAGIO clinical trial results demonstrating AZILECT's efficacy published

Results from the ADAGIO trial, published online today in The New England Journal of Medicine, demonstrated that Parkinson's disease patients receiving AZILECT (rasagiline) 1mg/day at the start of the study (early-start group) experienced superior benefit over 18 months compared with those who started the exact same treatment nine months later (delayed-start group).

Thiazolidinedione (TZD) class of anti-diabetic drugs may be a potential targeted therapy for myeloma patients

In laboratory tests on multiple myeloma cells, University of Rochester researchers found that this type of cancer expresses a protein that makes it an easy target for an existing class of diabetes drugs. After more investigation, they hope the discovery will lead to a new, targeted therapy for myeloma patients.

SonoSite to showcase the NanoMaxx ultrasound tool for vascular access applications at AVA

SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried and point-of-care ultrasound, announced today new patient safety technology, mobile power solutions and image quality advances for vascular access applications. The company will be showcasing the new products and capabilities at the annual scientific meeting of the Association for Vascular Access (AVA) being held in Las Vegas September 14th - 18th, 2009.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr James Thomas Barber Jr is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr James Thomas Barber Jr, DO
1631 Pathfinder Ave Unit A,
Jber, AK 99505-1318

Ph: (717) 615-1227
Dr James Thomas Barber Jr, DO
3831 Piper St Ste Sll020,
Anchorage, AK 99508-4699

Ph: (907) 212-3470

News Archive

Americans sicker but live longer than the English: Study

According to a new study in the journal Demographics, and elderly American is not quite as healthy as his English counterpart, but does live just as long, if not longer. The study found that Americans aged 55 to 64 and 70 to 80 had higher rates of chronic diseases than same-aged English people, but they died at about the same rate. Americans aged 65 and older could be sicker than their English peers but lived longer.

Champions Biotechnology signs agreement to test Cephalon's CEP-32496 in Biomerk Tumorgraft platform

Champions Biotechnology, Inc., an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, announced the establishment of an agreement with Cephalon, Inc., a global biopharmaceutical company, for the testing of the Cephalon novel B-Raf inhibitor CEP-32496 in Champions' Biomerk Tumorgraft™ platform.

ADAGIO clinical trial results demonstrating AZILECT's efficacy published

Results from the ADAGIO trial, published online today in The New England Journal of Medicine, demonstrated that Parkinson's disease patients receiving AZILECT (rasagiline) 1mg/day at the start of the study (early-start group) experienced superior benefit over 18 months compared with those who started the exact same treatment nine months later (delayed-start group).

Thiazolidinedione (TZD) class of anti-diabetic drugs may be a potential targeted therapy for myeloma patients

In laboratory tests on multiple myeloma cells, University of Rochester researchers found that this type of cancer expresses a protein that makes it an easy target for an existing class of diabetes drugs. After more investigation, they hope the discovery will lead to a new, targeted therapy for myeloma patients.

SonoSite to showcase the NanoMaxx ultrasound tool for vascular access applications at AVA

SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried and point-of-care ultrasound, announced today new patient safety technology, mobile power solutions and image quality advances for vascular access applications. The company will be showcasing the new products and capabilities at the annual scientific meeting of the Association for Vascular Access (AVA) being held in Las Vegas September 14th - 18th, 2009.

Read more News

› Verified 2 days ago


Obstetrics & Gynecology Doctors in Anchorage, AK

Dr. Wendy Sue Cruz, M.D.
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 2741 Debarr Rd Ste C205, Anchorage, AK 99508
Phone: 907-279-2273    Fax: 907-258-7705
Dr. Natalie Dawn Ward, M.D.
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 3260 Providence Dr, Ste. #425, Anchorage, AK 99508
Phone: 907-561-7111    Fax: 907-770-7891
Tania H Hall, MD
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 3260 Providence Dr, Ste 322, Anchorage, AK 99508
Phone: 907-563-5151    Fax: 907-563-6278
Anne Gray,
Obstetrics & Gynecology
Medicare: Medicare Enrolled
Practice Location: 4141 Ambassador Dr, Anchorage, AK 99508
Phone: 907-729-1542    
Mrs. Kristin M Murray, MD
Obstetrics & Gynecology
Medicare: Not Enrolled in Medicare
Practice Location: 4115 Lake Otis Pkwy, Anchorage, AK 99508
Phone: 907-563-7228    Fax: 907-563-6278
Kathryn Murphy, D.O.
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 4320 Diplomacy Dr, Anchorage, AK 99508
Phone: 907-729-3116    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.